Skip to content

Menu

Guarding the Lifeline of Dialysis Patients

Home
Team
Technology
News
Contact

Close Menu

Eileen Ke

About Eileen Ke

Posts by Eileen Ke:

March 14, 2025

PatenSee closes $2M seed round, appoints seasoned CEO, expands into Michigan

Eileen Ke Press Release

Home
Team
Technology
News
Contact

© Patensee 2025

Powered by: SPInc

PatenSee is a clinical-stage medical device company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients. Using advanced, multi-modal imaging technologies, AI and machine learning, PatenSee’s device alerts caregivers of vascular access stenosis risk at the earliest stage, enabling timely interventions to protect the patient’s hemodialysis lifeline, improve the quality of care and prolong the life of the fistula.

PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.